Synergistic Enhancement of Cisplatin Cytotoxicity by SN‐38, an Active Metabolite of CPT‐11, for Cisplatin‐resistant HeLa Cells

por Minagawa, Yukihisa, Kigawa, Junzo, Ishihara, Hiroshi, Itamochi, Hiroaki, Terakawa, Naoki
Publicado 1994

Relugolix, an oral gonadotropin-releasing hormone (GnRH) receptor antagonist, in women with endometriosis-associated pain: phase 2 safety and efficacy 24-week results

por Osuga, Yutaka, Seki, Yoshifumi, Tanimoto, Masataka, Kusumoto, Takeru, Kudou, Kentarou, Terakawa, Naoki
Publicado 2021

Enhanced Topoisomerase I Activity and Increased Topoisomerase IIα Content in Cisplatin‐resistant Cancer Cell Lines

por Minagawa, Yukihisa, Kigawa, Junzo, Irie, Takashi, Kanamori, Yasunobu, Itamochi, Hiroaki, Cheng, Xiusi, Terakawa, Naoki
Publicado 1997

Cisplatin‐resistant HeLa Cells Are Resistant to Apoptosis via p53‐dependent and ‐independent Pathways

por Minagawa, Yukihisa, Kigawa, Junzo, Itamochi, Hiroaki, Kanamori, Yasunobu, Shimada, Muneaki, Takahashi, Masakuni, Terakawa, Naoki
Publicado 1999

Sensitivity to Anticancer Agents and Resistance Mechanisms in Clear Cell Carcinoma of the Ovary

por Itamochi, Hiroaki, Kigawa, Junzo, Sultana, Habiba, Iba, Takahiro, Akeshima, Ryoji, Kamazawa, Shunji, Kanamori, Yasunobu, Terakawa, Naoki
Publicado 2002